» Articles » PMID: 23626820

Children's Phthalate Intakes and Resultant Cumulative Exposures Estimated from Urine Compared with Estimates from Dust Ingestion, Inhalation and Dermal Absorption in Their Homes and Daycare Centers

Overview
Journal PLoS One
Date 2013 Apr 30
PMID 23626820
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Total daily intakes of diethyl phthalate (DEP), di(n-butyl) phthalate (DnBP), di(isobutyl) phthalate (DiBP), butyl benzyl phthalate (BBzP) and di(2-ethylhexyl) phthalate (DEHP) were calculated from phthalate metabolite levels measured in the urine of 431 Danish children between 3 and 6 years of age. For each child the intake attributable to exposures in the indoor environment via dust ingestion, inhalation and dermal absorption were estimated from the phthalate levels in the dust collected from the child's home and daycare center. Based on the urine samples, DEHP had the highest total daily intake (median: 4.42 µg/d/kg-bw) and BBzP the lowest (median: 0.49 µg/d/kg-bw). For DEP, DnBP and DiBP, exposures to air and dust in the indoor environment accounted for approximately 100%, 15% and 50% of the total intake, respectively, with dermal absorption from the gas-phase being the major exposure pathway. More than 90% of the total intake of BBzP and DEHP came from sources other than indoor air and dust. Daily intake of DnBP and DiBP from all exposure pathways, based on levels of metabolites in urine samples, exceeded the Tolerable Daily Intake (TDI) for 22 and 23 children, respectively. Indoor exposures resulted in an average daily DiBP intake that exceeded the TDI for 14 children. Using the concept of relative cumulative Tolerable Daily Intake (TDI(cum)), which is applicable for phthalates that have established TDIs based on the same health endpoint, we examined the cumulative total exposure to DnBP, DiBP and DEHP from all pathways; it exceeded the tolerable levels for 30% of the children. From the three indoor pathways alone, several children had a cumulative intake that exceeded TDI(cum). Exposures to phthalates present in the air and dust indoors meaningfully contribute to a child's total intake of certain phthalates. Such exposures, by themselves, may lead to intakes exceeding current limit values.

Citing Articles

Phthalate Metabolites Were Related to the Risk of High-Frequency Hearing Loss: A Cross-Sectional Study of National Health and Nutrition Examination Survey.

You L, Zhang D, Lin C, Lan Q J Multidiscip Healthc. 2024; 17:5151-5161.

PMID: 39553265 PMC: 11568771. DOI: 10.2147/JMDH.S481288.


Novel Insights into Ethanol-Soluble Oyster Peptide-Zinc-Chelating Agents: Structural Characterization, Chelation Mechanism, and Potential Protection on MEHP-Induced Leydig Cells.

Lu Z, Huang Q, Qin X, Chen F, Li E, Lin H Mar Drugs. 2024; 22(10).

PMID: 39452873 PMC: 11509544. DOI: 10.3390/md22100465.


Dust phase and window film phase phthalates in dormitories: profile characteristics, source screening, and estimated gas-phase concentration and dermal exposure comparison.

Guo Z, Wang L, Li Y, Wu Z, Wang K, Duan J Environ Sci Pollut Res Int. 2024; 31(10):15257-15270.

PMID: 38291205 DOI: 10.1007/s11356-024-32019-4.


Opportunities in Assessing and Regulating Organohalogen Flame Retardants (OFRs) as a Class in Consumer Products.

Chen X, Birnbaum L, Babich M, de Boer J, White K, Barone Jr S Environ Health Perspect. 2024; 132(1):15001.

PMID: 38175186 PMC: 10766010. DOI: 10.1289/EHP12725.


Responses of peritubular macrophages and the testis transcriptome profiles of peripubertal and adult rodents exposed to an acute dose of MEHP.

Fang X, Tiwary R, Nguyen V, Richburg J Toxicol Sci. 2023; 198(1):76-85.

PMID: 38113427 PMC: 10901151. DOI: 10.1093/toxsci/kfad128.


References
1.
Kanazawa A, Saito I, Araki A, Takeda M, Ma M, Saijo Y . Association between indoor exposure to semi-volatile organic compounds and building-related symptoms among the occupants of residential dwellings. Indoor Air. 2009; 20(1):72-84. DOI: 10.1111/j.1600-0668.2009.00629.x. View

2.
Bosgra S, Bos P, Vermeire T, Luit R, Slob W . Probabilistic risk characterization: an example with di(2-ethylhexyl) phthalate. Regul Toxicol Pharmacol. 2005; 43(1):104-13. DOI: 10.1016/j.yrtph.2005.06.008. View

3.
Weschler C, Nazaroff W . SVOC exposure indoors: fresh look at dermal pathways. Indoor Air. 2012; 22(5):356-77. DOI: 10.1111/j.1600-0668.2012.00772.x. View

4.
Becker K, Seiwert M, Angerer J, Heger W, Koch H, Nagorka R . DEHP metabolites in urine of children and DEHP in house dust. Int J Hyg Environ Health. 2004; 207(5):409-17. DOI: 10.1078/1438-4639-00309. View

5.
Needham L, Calafat A, Barr D . Uses and issues of biomonitoring. Int J Hyg Environ Health. 2006; 210(3-4):229-38. DOI: 10.1016/j.ijheh.2006.11.002. View